marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-13-2024
Seres Therapeutics Cash Flow 2011-2024 | MCRB
Annual Cash Flow Seres Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-117 M | -229 M | 6.69 M | -93.6 M | -76.5 M | -62.9 M | -75.5 M | 43.9 M | - | - | - | - | - |
Depreciation & Amortization |
6.24 M | 6.63 M | 5.95 M | 6.58 M | 7.6 M | 7.86 M | 7.26 M | 4.2 M | 728 K | 190 K | 88 K | - | - |
Accounts Payables |
3.64 M | 17.4 M | 13.7 M | 4.02 M | 4.86 M | 6.42 M | 7.03 M | 7.59 M | 5.4 M | - | - | - | - |
Accounts Receivables |
- | - | - | - | 1.78 M | - | - | - | - | - | - | - | - |
Total Inventories |
29.6 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Seres Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -35.2 M | - | - | - | -76.6 M | - | -176 M | - | -66.4 M | - | 58.6 M | - | -29.5 M | - | -75.7 M | -49.8 M | -24.3 M | - | -62.5 M | -44.2 M | -32.4 M | - | -75.5 M | -52.4 M | -26.8 M | - | -54.9 M | -51.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
1.4 M | 1.42 M | 1.56 M | - | 1.68 M | 1.53 M | 1.4 M | - | 1.75 M | 1.68 M | 1.57 M | - | 1.49 M | 1.43 M | 1.48 M | - | 1.58 M | 1.69 M | 1.8 M | - | 1.88 M | 1.92 M | 2.01 M | - | 1.97 M | 1.95 M | 1.94 M | - | 1.87 M | 1.76 M | 1.73 M | - | 1.25 M | 874 K | 386 K | - | 182 K | 119 K | 92 K | - | 47 K | 36 K | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
8.25 M | 4.81 M | 5.22 M | 3.64 M | 8.96 M | 12.9 M | 12.3 M | 17.4 M | 10.4 M | - | 6.79 M | 13.7 M | 8.62 M | 5.45 M | 4.88 M | 4.02 M | 4.02 M | 4.02 M | 4.02 M | 4.86 M | 4.86 M | 4.86 M | 4.86 M | 6.42 M | 6.42 M | 6.42 M | 6.42 M | 7.03 M | 7.03 M | 7.03 M | 7.03 M | 7.59 M | 7.59 M | 7.59 M | 7.59 M | 5.4 M | 5.4 M | 5.4 M | 5.4 M | 2.17 M | 2.17 M | 2.17 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | 1.25 M | 1.25 M | 2.6 M | 9.39 M | 9.39 M | 9.39 M | 9.39 M | 1.78 M | 1.78 M | 1.78 M | 1.78 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | 53 M | 42 M | 29.6 M | 18.5 M | 5.34 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency